Below are the most recent publications written about "Psoriasis" by people in Profiles.
-
Loesch AJ, Jin A, Huang S, Motaparthi K, Lee JB, Hsu S. Methotrexate-Induced Epidermal Necrosis. Skinmed. 2024; 22(5):387-389.
-
Eyerich K, Asadullah K, Pinter A, Weisenseel P, Reich K, Paul C, Sabat R, Wolk K, Eyerich S, Lauffer F, Angsana J, Taut FJH, Kohler K, Chen Y, Sendecki J, Leung MWL, Wegner S, Personke Y, Gomez M, Kr?ger N, Tabori S, Sch?kel K. Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis: The GUIDE Randomized Clinical Trial. JAMA Dermatol. 2024 09 01; 160(9):953-963.
-
Lacouture ME, Goleva E, Shah N, Rotemberg V, Kraehenbuehl L, Ketosugbo KF, Merghoub T, Maier T, Bang A, Gu S, Salvador T, Moy AP, Lyubchenko T, Xiao O, Hall CF, Berdyshev E, Crooks J, Weight R, Kern JA, Leung DYM. Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways. Clin Cancer Res. 2024 Jul 01; 30(13):2822-2834.
-
Merola JF, Parish LC, Guenther L, Lynde C, Lacour JP, Staubach P, Cheng S, Paris M, Picard H, Deignan C, Jardon S, Chen M, Papp KA. Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol. 2024 03; 90(3):485-493.
-
Nazarian LN. Editorial comment on: the role of ultrasound in screening subclinical psoriatic arthritis among patients with moderate-to-severe psoriasis. Eur Radiol. 2023 06; 33(6):3941-3942.
-
Gleason L, Hunter E, Cohen A, Suriano J, Nikbakht N. Atezolizumab-induced psoriasiform drug eruption successfully treated with ixekizumab: a case report and literature review. Dermatol Online J. 2023 Feb 15; 29(1).
-
Endo Y, Tabara Y, Kawaguchi T, Onoufriadis A, McGrath JA, Matsuda F, Kabashima K. Metabolic syndrome and comorbidities in patients with psoriasis: a community-based case-control study from the Nagahama cohort in Japan. Eur J Dermatol. 2022 02 01; 32(1):86-93.
-
Schoenberg E, Wang JV, Keller M. Impact of Psoriasis on Quality of Life: A Qualitative Study Focused on Patient Perspectives. Skinmed. 2021; 19(6):438-439.
-
Jett JE, McLaughlin M, Lee MS, Parish LC, DuBois J, Raoof TJ, Tabolt G, Wilson T, Somerville MC, DellaMaestra W, Piscitelli SC. Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics. Am J Clin Dermatol. 2022 Jan; 23(1):83-91.
-
Valentine L, Norris MR, Bielory L. Comparison of structural components and functional mechanisms within the skin vs. the conjunctival surface. Curr Opin Allergy Clin Immunol. 2021 10 01; 21(5):472-479.